Entity

All; n, %

With PC

Without PC

Entity

with PC; n, %

Metastasis (%)

PCI

valuea;

n

Ki67

categorya; n

Karnofsky Indexa; n

Metastasis

(%)

PCI

value a;

n

Ki67

categorya; n

Karnofsky Indexa; n

All

132

89

68.5

11.0

(4.8, 19.0);

70*

35.0

(20.0, 60.0);

45

80.0

(70.0, 90.0);

82

67.4

0.0

(0.0, 8.5);

9

17.5

(14, 70);

4

80.0

(70.0, 90.0);

43

Colon

24, 12.2%

15, 62.5%

80.0

7.0

(3.0, 17.0);

11

60.0

(20.0, 70.0);

7

90.0

(80.0, 90.0);

13

55.6

4.0

(0, 28);

3

-;

0

80.0

(80.0, 90.0);

7

Gastric

13, 9.8%

10, 76.9%

50.0

6.0

(0.5, 16.0);

7

50.0

(26.0, 75.0);

5

80.0

(72.5, 87.5);

8

66.7

0.0;

1

-;

0

80.0

(70.0, 90.0);

3

GI#

12, 9.1%

10, 83.3%

70.0

10.5

(6.2, 18.0);

8

35.0

(20.0, 60.0);

7

75.0

(67.5, 90.0);

10

50.0

-;

0

19.0;

1

(80, 90);

2

Pancreas

23, 17.4%

12, 52.2%

75.0

15.5

(8.5, 20.5);

10

60.0

(25.0, 62.5);

6

80.0

(70.0, 88.8);

12

81.1

(2, 13);

2

-;

0

80.0

(77.5, 90.0);

10

Mamma

23, 17.4%

15, 65.2%

73.3

6.0

(0.5, 16.0);

13

20.0

(18.0, 40.0);

7

80.0

(70.0, 82.5);

14

75.0

-;

1

(14, 70);

2

75.0

(70.0, 87.5);

4

Ovarium

12, 9.2%

23, 92.0%

60.9

12.0

(5.0, 19.5);

17

25.0

(10.0, 70.0);

11

90.0

(80.0, 90.0);

21

50.0

-;

0

-;

0

(80.0, 90,0);

2

Others:

Lung cancer

Base of the tongue

Primary peritoneal

Peritoneum

Prostate

12, 9.2%

4

1

1

3

3

4, 66.7%

1

3

75.0

-; 1

-; 0

90.0; 1

62.5

-; 1

16.0; 1

80.0 (70.0,

90.0); 7